Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

Malaria

7 posts
NNovartis
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
Read More

Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants

  • 2026-04-24
Coartem® (artemether-lumefantrine) Baby is the first and only malaria treatment for newborns and young infants, closing long-standing treatment…
NNovartis
Vas Narasimhan on his rise to Novartis CEO
Read More

Vas Narasimhan on his rise to Novartis CEO

  • 2026-03-16
Guided by immigrant roots, public‑health purpose and a belief in “staying in the ring,” Novartis CEO Vas Narasimhan…
NNovartis
Turning personal experience into purpose-driven careers
Read More

Turning personal experience into purpose-driven careers

  • 2026-03-10
For Arti, Giselle and Maria their desire for purpose began with a moment that changed everything and grew…
GGeneva
Global Fund boss warns aid cuts jeopardise progress against malaria
Read More

Global Fund boss warns aid cuts jeopardise progress against malaria

  • 2026-03-08
Climate change, conflicts and a lack of funding compounded by recent aid cuts are hurting hard-won gains in…
NNovartis
Breaking ground in Global Health
Read More

Breaking ground in Global Health

  • 2026-02-25
This past year has been active at Novartis in the malaria space. What has it meant for your…
NNovartis
Eden Wells | Novartis United States of America
Read More

Novartis receives approval for first malaria medicine for newborn babies and young infants

  • 2026-02-13
Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight…
NNovartis
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery
Read More

Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance

  • 2026-02-12
Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem®…
Switzerland
www.europesays.com